# A Study of Elaprase in Children and Adults With Hunter Syndrome (Mucopolysaccharidosis II) in India

> **NCT05058391** · PHASE4 · COMPLETED · sponsor: **Takeda** · enrollment: 5 (actual)

## Conditions studied

- Hunter Syndrome

## Interventions

- **BIOLOGICAL:** Elaprase

## Key facts

- **NCT ID:** NCT05058391
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-21
- **Primary completion:** 2024-04-06
- **Final completion:** 2024-04-18
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2025-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05058391

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05058391, "A Study of Elaprase in Children and Adults With Hunter Syndrome (Mucopolysaccharidosis II) in India". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05058391. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*